Anticancer drug targets: growth factors and growth factor signaling.
Gibbs
J B
JB
WP16-101 Cancer Research, Department of Cancer Research, Merck Research Laboratories, Sumneytown Pike, West Point, Pennsylvania 19486, USA. jay_gibbs@merck.com
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D066246:ErbB Receptors / Q000037:antagonists & inhibitors*; D020558:GTP Phosphohydrolases / Q000037:antagonists & inhibitors*; D006801:Humans; D047428:Protein Kinase Inhibitors; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000037:antagonists & inhibitors*
D000970:Antineoplastic Agents; D066246:ErbB Receptors; D020558:GTP Phosphohydrolases; D047428:Protein Kinase Inhibitors; D018719:Erb-b2 Receptor Tyrosine Kinases